- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03008759
Evaluation in Vivo of Dentifrice With Nanoencapsulated Fluoride
Evaluation in Vivo of Experimental Dentifrice With Nanoencapsulated Fluoride
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Study design It is a quantitative study of double-blind randomized crossover clinical type with inductive approach and documentation of technical and direct observation with measurements in the laboratory.
In order to assess the bioavailability of intraoral fluoride week after the use of fluoride toothpastes containing Nanoencapsulated Fluoride, it will be collected biofilm samples 1h and 12 h after brushing; and unstimulated saliva in times of 3, 15, 30, 45, 60 minutes and 12 hours after. The data will be obtained by physical and chemical analysis of the samples of fluoride (F). Therefore, the study will consist of two interrelated steps: a clinical phase for biofilm collection and saliva; and laboratory stage for fluoride analysis in the samples.
Will be conducted pilot test with three participants before the start of the study.
- Sample Size The sample size calculation was performed using fluoride concentration data in dental biofilm previous study and taking effect size difference between the experimental dentifrice (100% Nanoencapsulated Fluoride ) and positive control of at least 3.4 ppm of F- in biofilm after 12 hours, namely, 25%. Admitting experimental protocol with beta error of 10% alpha error of 5%, one-tailed and statistical power of 90%, the sample size was calculated for 6 people. For the calculation we used the Excel software and mathematical formula for clinical trials of superiority given. Adding sample loss resulted in 12 people.
Experimental Dentifrice For this study will be used four toothpastes: 50% Nanoencapsulated Fluoride, 100% Nanoencapsulated Fluoride, Free sodium fluoride, Without fluoride. The toothpaste, made available by the company from Brazil are packed in the same packaging and have the taste of mint. Except wash out the tubes with toothpaste will be identified by letters (A, B and C) by an independent researcher. The letters code will not be revealed to the participants nor the researcher who will accompany them. These will be drawn at random for daily use for seven days in four times, giving an interval of one week wash-out between them.
In these periods of wash-out will use a toothpaste without fluoride. In the end, all study participants will use the 5 experimental dentifrice at different times.
Clinical phase The participant will be informed about the study and after its acceptance, he/she will initiate the study. Initially will be clinical examination in order to report the presence of any of the exclusion criteria already listed. After verifying the absence of these criteria, there will be a dental prophylaxis pumice for removal of this biofilm and in some cases may be made supragingival scraping. The patient will be advised not to make use of any fluoride product during the experiment. At first, volunteers are instructed to use a toothpaste without fluoride (wash out) the first week, in order to equate the study participants and eliminate any potential carryover effects of toothpaste used previously.
The participant will get a tube of toothpaste and will be instructed to brush their teeth for 1 minute and rinse with 10 mL of water twice a day (morning and night). On the seventh day, the participant will be instructed to brush only the occlusal surfaces of your teeth, to allow biofilm accumulation of flat surfaces. When going to bed, you are warned not to eat or drink (except water) as well as not brushing your teeth until the next day. On the following morning, approximately 12 hours after the last brushing and fasting, the first dental biofilm sample and unstimulated saliva is collected. It will be used to remove biofilm Hollenback vestibular faces, interproximal, palatal and lingual right hemiarch and deposited in a pre-weighed Eppendorf tube in an analytical balance. To saliva collection, the participant, at rest, will be instructed to spit for a minute in a graduated glass tube. After that, the participant will brush the occlusal surfaces for 1 min and rinse with 10 mL of water. Soon after, will new collection of saliva and plaque. Saliva samples will give up in times of 3, 15, 30, 45 and 60 minutes after brushing, while the biofilm left hemiarch will be collected one hour after brushing. After the collection will be offered at breakfast organized by researchers participating in the crown of that research center.
- Laboratorial phase Samples will be evaluated through physical-chemical analysis of fluoride using calibrated fluoride electrode. Samples will be analyzed for fluoride concentration using ion-specific electrode after diffusion facilitated with hexamethyl disiloxane (HMDS). The calibration curve is made for each analysis. All analyzes will be done in triplicate and be submitted for validation.
- Data analysis The study data will be analyzed by inferential statistics considering p <0.05.
Type d'étude
Inscription (Anticipé)
Phase
- Phase 2
- La phase 1
Contacts et emplacements
Lieux d'étude
-
-
Paraíba
-
Joao Pessoa, Paraíba, Brésil
- Federal University of Paraíba
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- resident in João Pessoa
- Decayed, Missing, Filled Index<6
- Healthy
Exclusion Criteria:
- orthodontic treatment
- gingivitis
- Periodontal disease
- Smokers
- Present active tooth decay
- Tooth sensitivity
- Those undergoing treatment with fluoride products and / or use of antimicrobials in the past four weeks
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Tripler
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur placebo: Placebo
Dentifrice without fluoride
|
Use of few of dentifrice 100% Nanoencapsulated Fluoride on brushing for one week, twice day.
Use of few of dentifrice 50% Nanoencapsulated Fluoride on brushing for one week, twice day.
Use of few of dentifrice on brushing for one week, twice day.
It's for the positive control of fluorid
|
|
Comparateur actif: Dentifrice standard
Dentifrice 1100 ppm sodium fluoride (NaF).
Positive control
|
Use of few of dentifrice on brushing for one week, twice day.
It's for the positive control of fluorid
|
|
Expérimental: Dentifrice 50% Nano-F
Dentifrice experimental with Fluoride being half of fluoride Nanoencapsulated and other half freeform of NaF
|
Use of few of dentifrice 50% Nanoencapsulated Fluoride on brushing for one week, twice day.
|
|
Expérimental: Dentifrice 100% Nano-F
Dentifrice experimental with fluoride 100% Nanoencapsulated
|
Use of few of dentifrice 100% Nanoencapsulated Fluoride on brushing for one week, twice day.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Bioavailability of intraoral fluoride (biofilm and saliva)
Délai: six months
|
collection of dental plaque(biofilm) and saliva
|
six months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: Fábio Sampaio, Doctor, University Federal of Paraiba
Publications et liens utiles
Publications générales
- Buzalaf MA, Vilhena FV, Iano FG, Grizzo L, Pessan JP, Sampaio FC, Oliveira RC. The effect of different fluoride concentrations and pH of dentifrices on plaque and nail fluoride levels in young children. Caries Res. 2009;43(2):142-6. doi: 10.1159/000211717. Epub 2009 Apr 8.
- Whitford GM, Wasdin JL, Schafer TE, Adair SM. Plaque fluoride concentrations are dependent on plaque calcium concentrations. Caries Res. 2002 Jul-Aug;36(4):256-65. doi: 10.1159/000063931.
- Pessan JP, Silva SM, Lauris JR, Sampaio FC, Whitford GM, Buzalaf MA. Fluoride uptake by plaque from water and from dentifrice. J Dent Res. 2008 May;87(5):461-5. doi: 10.1177/154405910808700501.
- Pessan JP, Pinto Alves KM, Italiani Fde M, Ramires I, Lauris JR, Whitford GM, Toumba KJ, Robinson C, Buzalaf MA. Distribution of fluoride and calcium in plaque biofilms after the use of conventional and low-fluoride dentifrices. Int J Paediatr Dent. 2014 Jul;24(4):293-302. doi: 10.1111/ipd.12073.
- Pessan JP, Conceicao JM, Grizzo LT, Szekely M, Fazakas Z, Buzalaf MA. Intraoral fluoride levels after use of conventional and high-fluoride dentifrices. Clin Oral Investig. 2015 May;19(4):955-8. doi: 10.1007/s00784-015-1426-3. Epub 2015 Feb 14.
- Duckworth RM, Jones S. On the relationship between the rate of salivary flow and salivary fluoride clearance. Caries Res. 2015;49(2):141-6. doi: 10.1159/000365949. Epub 2015 Jan 27.
- Duckworth RM, Morgan SN, Gilbert RJ. Oral fluoride measurements for estimation of the anti-caries efficacy of fluoride treatments. J Dent Res. 1992 Apr;71 Spec No:836-40. doi: 10.1177/002203459207100S09.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- NanoF
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Caries dentaires
-
The Affiliated Hospital of Xuzhou Medical UniversityRecrutementLLC | SLL | Thérapie cellulaire CAR-TChine
-
Xuzhou Medical UniversityPas encore de recrutementSurveillance non invasive des cellules CAR-T | Imagerie PET ciblant le BCMA | Biodistribution et persistance des cellules CAR-T | Préparation de Radiopharmaceutique Conforme aux BPF
-
University Health Network, TorontoPas encore de recrutement
-
Patrick C. Johnson, MDRecrutement
-
Duke UniversityNational Institutes of Health (NIH)RecrutementGreffe de cellules souches hématopoïétiques | Thérapie cellulaire CAR-TÉtats-Unis
-
The Lymphoma Academic Research OrganisationBristol-Myers Squibb; Novartis; Gilead SciencesRecrutementÉligible en hématopathologie ou traitement CAR-t CellFrance
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecrutementComplications de la thérapie CAR-TItalie
-
Shanghai International Medical CenterInconnueTumeur solide avancée | PD-1 Anticorps | Cellules CAR-TChine
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Palleos Healthcare GmbHRecrutementMesures des résultats rapportés par les patients | Thérapie CAR T-CellSuisse
-
Ruijin HospitalActif, ne recrute pasALL (leucémie aiguë B-lymphoblastique) | Thérapie cellulaire CAR-TChine
Essais cliniques sur Dentifrice 100% Nano-F
-
Fabio Correia SampaioComplété
-
International Centre for Diarrhoeal Disease Research...London School of Hygiene and Tropical MedicineComplétéNourrissons sévèrement malnutris âgés de moins de 6 moisBengladesh
-
St Stephens Aids TrustUniversity of LiverpoolSuspendu
-
Indiana UniversityHALEONComplété
-
British University In EgyptComplétéEffet de la drogue | Maladie pulmonaire
-
Organon and CoComplété
-
Baylor College of MedicineComplétéInfection par l'ankylostome | AnkylostomiaseBrésil
-
Merck KGaA, Darmstadt, GermanyComplété